{"id":"NCT00262600","sponsor":"Boehringer Ingelheim","briefTitle":"Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate","officialTitle":"Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2009-04","completion":null,"firstPosted":"2005-12-07","resultsPosted":"2011-02-10","lastUpdate":"2019-04-17"},"enrollment":18113,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":null,"primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation","Stroke"],"interventions":[{"type":"DRUG","name":"warfarin","otherNames":[]},{"type":"DRUG","name":"Dabigatran dose 1","otherNames":[]},{"type":"DRUG","name":"Dabigatran dose 2","otherNames":[]}],"arms":[{"label":"Dabigatran dose 2","type":"ACTIVE_COMPARATOR"},{"label":"Warfarin","type":"ACTIVE_COMPARATOR"},{"label":"Dabigatran dose 1","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.","primaryOutcome":{"measure":"Yearly Event Rate for Composite Endpoint of Stroke/SEE","timeFrame":"36 months","effectByArm":[{"arm":"Dabigatran 110 mg","deltaMin":1.54,"sd":null},{"arm":"Dabigatran 150 mg","deltaMin":1.11,"sd":null},{"arm":"Warfarin","deltaMin":1.71,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<.0001"},{"comp":"OG001 vs OG002","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":984,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","China","Colombia","Czechia","Denmark","Finland","France","Germany","Greece","Hong Kong","Hungary","India","Israel","Italy","Japan","Malaysia","Mexico","Netherlands","Norway","Peru","Philippines","Poland","Portugal","Romania","Russia","Singapore","Slovakia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["36990261","34411158","34358298","33757788","33741689","33292046","32984892","32385506","31046423","30651032","30012318","29653640","29069359","28520924","28213368","27569438","27496855","27056738","26818781","26678637","26093161","26065986","24794140","24359765","24323795","24081972","24076487","24016454","23770182","23743976","23467860","23271794","23103906","23027801","22700854","22374183","22215856","22084332","21576658","21200007","21147728","21059484","20801496","19717844","19376304"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1263,"n":5983},"commonTop":["Dyspnoea","Dizziness","Oedema peripheral","Fatigue","Diarrhoea"]}}